Everfront Biotech Inc.- Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs

by developing orphan drugs to treat the world’s most lethal diseases including high grade glioma and pancreatic cancer

Brain Tumor (Glioblastoma, GBM) and Pancreatic Cancer (PC)

EFB'S Mission

EFB’s Mission

EFB is committed to fulfilling unmet medical needs

Rising Star in Pharmaceutical Innovation

Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases.

Cerebraca® Wafer

Curing Rare Cancer

Curing Rare Cancers

Including
Glioblastoma (GBM) and
Pancreatic cancer (PC)

EF-009 | PC Treatment

PRODUCT HIGHLIGHTS of Cerebraca® Wafer

A Biodegradable Implant Targeting GBM with One-month Sustained Drug Release

Latest News

Everfront Biotech to Unveil Breakthrough Clinical Trial Results for Cerebraca® Wafer in Brain Cancer Treatment at 2024 Taiwan Healthcare+ Expo

Taiwan’s Biotech and Pharma Delegation: Innovations Take Center Stage at BIO 2024

Everfront Biotech at BIO 2024: Showcasing Clinical Achievements alongside 47 Global Startups

Explore Everfront Biotech

We look forward to hearing from you.

Development Pipeline